Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Vogel

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 24, 2018
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
The American Journal of Cardiology|October 2, 2018
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)Sabato Sorrentino, Gennaro Giustino, Usman Baber, et al.
Circulation. Cardiovascular Interventions|March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS RegistrySabato Sorrentino, Samantha Sartori, Usman Baber, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.
International Journal of Cardiology|November 5, 2018
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary interventionMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2017
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trialAxel Linke, Jaya Chandrasekhar, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 12, 2017
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trialChristian Hengstenberg, Jaya Chandrasekhar, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS RegistryLauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
The American Journal of Cardiology|October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT TrialUsman Baber, Alessandro Spirito, Samantha Sartori, et al.
Thrombosis and Haemostasis|August 1, 2019
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS RegistryBirgit Vogel, Jaya Chandrasekhar, Usman Baber, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 24, 2018
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
The American Journal of Cardiology|October 2, 2018
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)Sabato Sorrentino, Gennaro Giustino, Usman Baber, et al.
Circulation. Cardiovascular Interventions|March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS RegistrySabato Sorrentino, Samantha Sartori, Usman Baber, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.
International Journal of Cardiology|November 5, 2018
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary interventionMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2017
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trialAxel Linke, Jaya Chandrasekhar, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 12, 2017
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trialChristian Hengstenberg, Jaya Chandrasekhar, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS RegistryLauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
The American Journal of Cardiology|October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT TrialUsman Baber, Alessandro Spirito, Samantha Sartori, et al.
Thrombosis and Haemostasis|August 1, 2019
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS RegistryBirgit Vogel, Jaya Chandrasekhar, Usman Baber, et al.
Pageof 19